Low early ototoxicity rates for pediatric medulloblastoma patients treated with proton radiotherapy

BACKGROUND: Hearing loss is common following chemoradiotherapy for children with medulloblastoma. Compared to photons, proton radiotherapy reduces radiation dose to the cochlea for these patients. Here we examine whether this dosimetric advantage leads to a clinical benefit in audiometric outcomes....

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Moeller, Benjamin J, Chintagumpala, Murali, Philip, Jimmy J, Grosshans, David R, McAleer, Mary F, Woo, Shiao Y, Gidley, Paul W, Vats, Tribhawan S, Mahajan, Anita
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2011
Предметы:
Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3123575/
https://ncbi.nlm.nih.gov/pubmed/21635776
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1748-717X-6-58
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы